Eggerthella lenta bacteremia successfully treated with ceftizoxime: case report and review of the literature

9Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Eggerthella lenta is a normal human microflora that is anaerobic, non-sporulating, and Gram positive. However, an increasing number of studies have shown that it could also be an important pathogen for humans, even causing life-threatening infection under certain conditions. However, understanding its pathogenic mechanism and treatment options still need to be improved; more clinical data are needed to explore it further. In this article, we report a case of ceftizoxime-cured E. lenta bacteremia and review the recent literature to provide more clinical data for the diagnosis of E. lenta bacteremia. Our report suggests that the frequency of E. lenta bacteremia is increased in patients with hematologic or solid organ cancer, diabetes mellitus and also in those with appendicitis.

Cite

CITATION STYLE

APA

Jiang, S., Jianfei, E., Wang, D., Zou, Y., Liu, X., Xiao, H., … Chen, Z. (2021, December 1). Eggerthella lenta bacteremia successfully treated with ceftizoxime: case report and review of the literature. European Journal of Medical Research. BioMed Central Ltd. https://doi.org/10.1186/s40001-021-00582-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free